Chimerix Is A Biopharmaceutical Company Based In Durhamnorth Carolinaand Is A Subsidiary Of Jazz Pharmaceuticals Following Its Acquisition In April 2025The Company Is Dedicated To Developing Innovative Medicines Aimed At Improving And Extending The Lives Of Patients With Serious And Life Threatening Diseasesparticularly In The Areas Of Cancer Chimerix Has Notable Products Including Dordavipronewhich Is Under Fda Review As A Treatment For Recurrent H3 K27M Mutant Diffuse Gliomaand Brincidofovirwhich Was Approved For Potential Use In Patients With Ebola Virus Diseasethe Company Also Offers Expanded Access Programs For Healthcare Professionals Interested In Its Drug Candidateswith A Workforce Of Approximately 79 Employeeschimerix Continues To Enhance Its Capabilities In Developing Life Changing Medicines As Part Of Jazz Pharmaceuticalsbroader Mission
